Peptide eye creams typically feature one or more of these active peptides: dipeptides (Matrixyl, diaminopropionoyl tripeptide-33 / "Argireline"), tripeptides (hexapeptide-48), or proprietary peptide complexes (pentapeptides, nonapeptides). Each category differs in cost, efficacy claims, regulatory status, and stability requirements. A Matrixyl-type dipeptide (palmitoyl tripeptide-1 or palmitoyl dipeptide-5) costs $60–$120 per kilogram and is typically dosed at 2–5% in the formula; an Argireline-equivalent (acetyl hexapeptide-8) costs $80–$150 per kilogram at 2–4% dosing; a branded or patented pentapeptide complex (e.g., Syn-Ake, a snake-venom peptide mimic, or Matrixyl 3000, which combines peptides with hyaluronic acid) costs $150–$400 per kilogram at 3–8% dosing. The per-unit ingredient cost for a 30 ml eye cream typically ranges from $0.15 to $1.20 depending on peptide type and concentration.
Matrixyl (palmitoyl tripeptide-1) and its analogs are the most widely used and cost-effective option for indie brands entering the peptide eye cream market. They are INCI-approved, stable across a wide pH range (4–7), compatible with most preservatives, and have a long history of use in anti-aging skincare. At 3–5% concentration, Matrixyl delivers a credible claim of supporting collagen production and is recognized by formulators and consumers as a legitimate active. A 1,000-unit batch with 3% Matrixyl costs approximately $0.20–$0.40 per unit in peptide material alone. The downside is that Matrixyl is also widely used in competitor private labels and mass-market brands, so differentiation is harder. Regulatory risk is minimal: Matrixyl is approved in the US (INCI nomenclature), EU, Canada, and most major markets without additional substantiation, though you should always check the latest CPNP or FDA status with your manufacturer.
Argireline-type peptides (acetyl hexapeptide-8, also called hexapeptide-3 or by the brand name Argireline) cost slightly more ($80–$150/kg) but offer a distinct marketing angle: they are claimed to relax facial micro-expressions and reduce the appearance of fine lines, positioning the product as a non-invasive alternative to Botox-like treatments. Acetyl hexapeptide-8 is INCI-approved and widely available, but regulatory status varies by region. In the US it is acceptable as a cosmetic ingredient; in the EU it is approved under CPNP; in some Asian markets (e.g., China) regulatory approval may require additional dossier submission. At 2–4% concentration in an eye cream, the per-unit cost is $0.25–$0.60. Many indie founders use a blend: 2% Matrixyl + 2% Argireline to combine collagen-support and expression-relaxing claims, which increases the active cost to $0.45–$0.80 per unit but justifies a higher retail price.
Proprietary and branded peptides (Syn-Ake, Matrixyl 3000, Eyeseryl, Lipopeptide-Complex) offer premium positioning and can command retail prices 30–50% higher than single-peptide formulas, but they come with regulatory and cost trade-offs. Syn-Ake (a pentapeptide that mimics the structure of snake venom) costs $250–$400 per kilogram and must be dosed at 5–10% to deliver claims; at a 1,000-unit MOQ, the per-unit cost is $0.50–$1.20 just for the peptide. Eyeseryl (dipeptide diaminobutyroyl benzylamidopropanoate) is positioned for reducing eye puffiness and costs $150–$300/kg at 2–5% dosing, contributing $0.20–$0.80 per unit. These premium peptides often come with research data and usage guidelines from their manufacturers, reducing your formulation risk but increasing your COGS and your retail price pressure.
When selecting a peptide, balance cost, efficacy, regulatory approval, and consumer appeal. A Matrixyl-based eye cream at $12/unit COGS can retail at $35–$45 and remain competitive; an Argireline blend at $14/unit COGS can justify $45–$55; a premium complex (Syn-Ake + Argireline + hyaluronic acid) at $18/unit COGS requires a $65–$85 retail price to sustain a healthy margin, which limits your addressable market to premium DTC or high-end retail. Most indie founders starting with low MOQ choose a 2–3 peptide blend (Matrixyl + Argireline + one botanical extract peptide equivalent, such as a mushroom or plant-derived peptide alternative) because it delivers a credible story, keeps COGS under $15/unit, and avoids the premium price barrier.
One critical stability consideration: peptides degrade under heat, light, and in acidic environments. Ensure your formulation pH stays between 4.5 and 6.5, avoid heat-processing if possible, and use opaque or UV-blocking packaging (airless pumps or dark glass). Some peptides benefit from stabilizing ingredients like ferulic acid or vitamin E, which add another $0.10–$0.30 per unit. When requesting a quote on AJ Cosmo Labs, specify your desired peptide(s), concentration, and any stability or regulatory concerns; vetted formulators and manufacturers will confirm compatibility and flag hidden costs (e.g., a rare peptide may have a 4-week lead time, pushing your production timeline).
Ingredients in this answer: Hyaluronic Acid · Argireline · Ferulic Acid
Read the full guide on Private Label Peptide Eye Cream Manufacturer Low MOQ Guide →